Clinical Trial Supply & Logistics For Pharmaceutical Market: By Service Type, By Phase, By Therapeutic Area, and Geography
Clinical Trial Supply and Logistics for Pharmaceutical Market size was valued at approximately US$ 15,629.7 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2030. This market encompasses services related to the manufacturing, packaging, labeling, storage, and distribution of clinical trial materials for pharmaceutical companies. The growth is primarily driven by the increasing number of clinical trials, rising complexity of trial designs, and the globalization of clinical research. According to ClinicalTrials.gov, as of May 2023, there were over 430,000 registered studies across 221 countries, indicating the vast scale of clinical trial activities worldwide.
The COVID-19 pandemic has further accelerated market growth by highlighting the importance of efficient supply chain management in clinical trials, with many companies adopting decentralized trial models. Additionally, the increasing focus on personalized medicine and rare diseases is contributing to the demand for specialized logistics services. The Tufts Center for the Study of Drug Development reported that rare disease trials grew by 88% between 2011 and 2020, requiring more complex supply chain solutions. However, challenges such as stringent regulatory requirements, temperature control issues, and the need for real-time tracking of clinical supplies may hinder market growth to some extent. The market is also influenced by technological advancements, with the integration of blockchain and IoT devices for enhanced traceability and temperature monitoring becoming increasingly prevalent.
Study Period
2024-2030Base Year
2023CAGR
7.1%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The clinical trial supply and logistics for pharmaceutical market is witnessing significant growth in the packaging and labeling segment due to the increasing complexity of clinical trials and the need for customized packaging solutions. The rise of adaptive trial designs and patient-centric approaches has led to a demand for flexible packaging that can accommodate mid-study changes. According to a survey by the Tufts Center for the Study of Drug Development, 94% of pharmaceutical companies reported using adaptive trial designs in some of their clinical studies. This trend is driving innovation in packaging technologies, such as smart labels and temperature-sensitive packaging materials. The integration of RFID technology in clinical trial packaging has improved inventory management and reduced medication errors. The cold chain logistics segment is also experiencing substantial growth, driven by the increasing number of temperature-sensitive biopharmaceuticals in clinical trials. Biopharma products now account for over 40% of the pharmaceutical industry pipeline, as reported by the Pharmaceutical Research and Manufacturers of America (PhRMA) in 2022. This shift towards biologics has intensified the need for sophisticated cold chain solutions, including real-time temperature monitoring and specialized storage facilities.
Based on regions the clinical trial supply and logistics for pharmaceutical market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is expected to dominate the clinical trial supply and logistics market, accounting for approximately 40% of the global market share. This dominance is attributed to the high concentration of pharmaceutical and biotechnology companies in the region, substantial R&D investments, and a well-established regulatory framework. The U.S. alone conducts about 40% of all clinical trials globally, according to the National Institutes of Health. The region's market is characterized by advanced technologies such as AI-driven supply chain optimization and robotic automation in warehousing. Europe follows closely, holding about 25% of the market share, driven by a strong presence of contract research organizations (CROs) and increasing government support for clinical research. The European Medicines Agency's (EMA) efforts to harmonize clinical trial regulations across the EU have further streamlined logistics operations in the region. The Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, with a CAGR of around 9%. This growth is fueled by the increasing outsourcing of clinical trials to countries like China and India, which offer large patient populations and lower operational costs. For instance, the number of clinical trials in China grew by 500% between 2010 and 2020, as reported by the Chinese Clinical Trial Registry. The region is also seeing a rise in local cold chain capabilities and specialized clinical trial logistics providers.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 15,629.7 million |
|
Market CAGR |
7.1% |
|
By Service Type |
|
|
By Phase |
|
|
By Therapeutic Area |
|
|
By Region |
|
Download Free Sample Report
The global clinical trial supply and logistics for pharmaceutical market was valued at approximately US$ 15,629.7 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2030.
The leading players in the clinical trial supply & logistics for pharmaceutical market include Catalent, Inc., ThermoFisher Scientific Inc., Almac Group, Parexel International Corporation, and UPS Healthcare, among others.
The growth is driven by increasing clinical trials, growing complexity of trial designs, globalization of clinical research, rising focus on personalized medicine, and the need for specialized logistics for biologics and rare disease trials.
The restraints include stringent regulatory requirements, challenges in maintaining temperature control, high costs associated with specialized logistics, and the need for real-time tracking and data management of clinical supplies.
| 1.Executive Summary |
| 2.Global Clinical Trial Supply & Logistics For Pharmaceutical Market Introduction |
| 2.1.Global Clinical Trial Supply & Logistics For Pharmaceutical Market - Taxonomy |
| 2.2.Global Clinical Trial Supply & Logistics For Pharmaceutical Market - Definitions |
| 2.2.1. Service Type |
| 2.2.2.Phase |
| 2.2.3.Therapeutic Area |
| 2.2.4.Region |
| 3.Global Clinical Trial Supply & Logistics For Pharmaceutical Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Clinical Trial Supply & Logistics For Pharmaceutical Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Clinical Trial Supply & Logistics For Pharmaceutical Market By Service Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Manufacturing |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Packaging and Labeling |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Distribution and Storage |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Clinical Trial Supply & Logistics For Pharmaceutical Market By Phase, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Phase I |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Phase II |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Phase III |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Phase IV |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Clinical Trial Supply & Logistics For Pharmaceutical Market By Therapeutic Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Oncology |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. CNS |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Cardiovascular |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Infectious Diseases |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Clinical Trial Supply & Logistics For Pharmaceutical Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Service Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Manufacturing |
| 9.1.2.Packaging and Labeling |
| 9.1.3.Distribution and Storage |
| 9.2. Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Phase I |
| 9.2.2.Phase II |
| 9.2.3.Phase III |
| 9.2.4.Phase IV |
| 9.3. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Oncology |
| 9.3.2.CNS |
| 9.3.3.Cardiovascular |
| 9.3.4.Infectious Diseases |
| 9.3.5.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Service Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Manufacturing |
| 10.1.2.Packaging and Labeling |
| 10.1.3.Distribution and Storage |
| 10.2. Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Phase I |
| 10.2.2.Phase II |
| 10.2.3.Phase III |
| 10.2.4.Phase IV |
| 10.3. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Oncology |
| 10.3.2.CNS |
| 10.3.3.Cardiovascular |
| 10.3.4.Infectious Diseases |
| 10.3.5.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Service Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Manufacturing |
| 11.1.2.Packaging and Labeling |
| 11.1.3.Distribution and Storage |
| 11.2. Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Phase I |
| 11.2.2.Phase II |
| 11.2.3.Phase III |
| 11.2.4.Phase IV |
| 11.3. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Oncology |
| 11.3.2.CNS |
| 11.3.3.Cardiovascular |
| 11.3.4.Infectious Diseases |
| 11.3.5.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Service Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Manufacturing |
| 12.1.2.Packaging and Labeling |
| 12.1.3.Distribution and Storage |
| 12.2. Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Phase I |
| 12.2.2.Phase II |
| 12.2.3.Phase III |
| 12.2.4.Phase IV |
| 12.3. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Oncology |
| 12.3.2.CNS |
| 12.3.3.Cardiovascular |
| 12.3.4.Infectious Diseases |
| 12.3.5.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Clinical Trial Supply & Logistics For Pharmaceutical Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Service Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Manufacturing |
| 13.1.2.Packaging and Labeling |
| 13.1.3.Distribution and Storage |
| 13.2. Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Phase I |
| 13.2.2.Phase II |
| 13.2.3.Phase III |
| 13.2.4.Phase IV |
| 13.3. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Oncology |
| 13.3.2.CNS |
| 13.3.3.Cardiovascular |
| 13.3.4.Infectious Diseases |
| 13.3.5.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Catalent, Inc. |
| 14.2.2.Thermo Fisher Scientific Inc. |
| 14.2.3.Almac Group |
| 14.2.4.Parexel International Corporation |
| 14.2.5.UPS Healthcare |
| 14.2.6.Marken (a UPS company) |
| 14.2.7.PCI Pharma Services |
| 14.2.8.Sharp |
| 14.2.9.Biocair |
| 14.2.10.World Courier |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
